Evaluation of wet pasteurization of a factor VIII concentrate produced by controlled-pore silica adsorption.

H Hiemstra, C E Nieuweboer, M A Idoe, J E Claassen, A H Vos, M Tersmette, P F Strengers, J Over, E P Mauser-Bunschoten, H Heijboer
{"title":"Evaluation of wet pasteurization of a factor VIII concentrate produced by controlled-pore silica adsorption.","authors":"H Hiemstra,&nbsp;C E Nieuweboer,&nbsp;M A Idoe,&nbsp;J E Claassen,&nbsp;A H Vos,&nbsp;M Tersmette,&nbsp;P F Strengers,&nbsp;J Over,&nbsp;E P Mauser-Bunschoten,&nbsp;H Heijboer","doi":"","DOIUrl":null,"url":null,"abstract":"<p><p>In the routine production of a factor VIII concentrate (produced by adsorption of contaminating proteins in cryoprecipitate to controlled-pore silica and concentration of the factor VIII effluent by ultrafiltration) the terminal dry-heat treatment has been replaced by pasteurization in the liquid state. High effectivity of this procedure with respect to virus inactivation was demonstrated using a variety of both lipid- and protein-enveloped model viruses, including HIV. Pair-wise quality control of dry-heated and pasteurized product revealed no significant differences, except in the composition of the formulation buffer. In a clinical study in which 17 patients with haemophilia A participated the pasteurized product was well tolerated and in vivo recovery and half-life of factor VIII were in the same (normal) range as found for the dry-heated counterpart.</p>","PeriodicalId":75853,"journal":{"name":"Folia haematologica (Leipzig, Germany : 1928)","volume":"117 4","pages":"557-63"},"PeriodicalIF":0.0000,"publicationDate":"1990-01-01","publicationTypes":"Journal Article","fieldsOfStudy":null,"isOpenAccess":false,"openAccessPdf":"","citationCount":"0","resultStr":null,"platform":"Semanticscholar","paperid":null,"PeriodicalName":"Folia haematologica (Leipzig, Germany : 1928)","FirstCategoryId":"1085","ListUrlMain":"","RegionNum":0,"RegionCategory":null,"ArticlePicture":[],"TitleCN":null,"AbstractTextCN":null,"PMCID":null,"EPubDate":"","PubModel":"","JCR":"","JCRName":"","Score":null,"Total":0}
引用次数: 0

Abstract

In the routine production of a factor VIII concentrate (produced by adsorption of contaminating proteins in cryoprecipitate to controlled-pore silica and concentration of the factor VIII effluent by ultrafiltration) the terminal dry-heat treatment has been replaced by pasteurization in the liquid state. High effectivity of this procedure with respect to virus inactivation was demonstrated using a variety of both lipid- and protein-enveloped model viruses, including HIV. Pair-wise quality control of dry-heated and pasteurized product revealed no significant differences, except in the composition of the formulation buffer. In a clinical study in which 17 patients with haemophilia A participated the pasteurized product was well tolerated and in vivo recovery and half-life of factor VIII were in the same (normal) range as found for the dry-heated counterpart.

控制孔二氧化硅吸附生产的因子VIII浓缩物的湿法巴氏灭菌评价。
在因子VIII浓缩物的常规生产中(通过将冷冻沉淀中的污染蛋白质吸附到控制孔二氧化硅上并通过超滤浓缩因子VIII流出物而生产),末端干热处理已被液态巴氏灭菌所取代。使用包括HIV在内的多种脂质和蛋白质包膜模型病毒,证明了该程序在病毒失活方面的高效性。干加热和巴氏灭菌产品的成对质量控制显示,除了配方缓冲液的组成外,没有显着差异。在一项有17名a型血友病患者参与的临床研究中,巴氏灭菌产品耐受性良好,体内恢复和因子VIII的半衰期与干热产品相同(正常)。
本文章由计算机程序翻译,如有差异,请以英文原文为准。
求助全文
约1分钟内获得全文 求助全文
来源期刊
自引率
0.00%
发文量
0
×
引用
GB/T 7714-2015
复制
MLA
复制
APA
复制
导出至
BibTeX EndNote RefMan NoteFirst NoteExpress
×
提示
您的信息不完整,为了账户安全,请先补充。
现在去补充
×
提示
您因"违规操作"
具体请查看互助需知
我知道了
×
提示
确定
请完成安全验证×
copy
已复制链接
快去分享给好友吧!
我知道了
右上角分享
点击右上角分享
0
联系我们:info@booksci.cn Book学术提供免费学术资源搜索服务,方便国内外学者检索中英文文献。致力于提供最便捷和优质的服务体验。 Copyright © 2023 布克学术 All rights reserved.
京ICP备2023020795号-1
ghs 京公网安备 11010802042870号
Book学术文献互助
Book学术文献互助群
群 号:481959085
Book学术官方微信